Hodges Capital Management’s Novo Nordisk NVO Stock Holding History

Hodges Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.46M	Buy	+51,300	New	+$2.2M	0.16%	125
2025 Q3	–	Sell	-4,842	Closed	-$334K	–	219
2025 Q2	$334K	Sell	4,842 -147	-3%	-$10K	0.03%	176
2025 Q1	$346K	Sell	4,989 -23,225	-82%	-$1.92M	0.03%	185
2024 Q4	$3.72M	Sell	28,214 -60,012	-68%	-$6.49M	0.22%	115
2024 Q3	$10.5M	Sell	88,226 -9,342	-10%	-$1.25M	0.67%	46
2024 Q2	$13.9M	Sell	97,568 -61,490	-39%	-$8.15M	0.93%	28
2024 Q1	$20.4M	Sell	159,058 -39,684	-20%	-$4.72M	1.3%	21
2023 Q4	$20.6M	Buy	198,742 +121,078	+156%	+$12M	1.09%	26
2023 Q3	$9.08M	Sell	77,664 -13,644	-15%	-$1.2M	1.08%	27
2023 Q2	$9.49M	Buy	91,308 +6,222	+7%	+$508K	0.55%	57
2023 Q1	$7.72M	Buy	85,086 +19,992	+31%	+$1.42M	0.63%	50
2022 Q4	$7.9M	Buy	65,094 +60,094	+1,202%	+$3.52M	0.68%	48
2022 Q3	$249K	Hold	5,000	–	–	0.04%	190
2022 Q2	$279K	Hold	5,000	–	–	0.03%	198
2022 Q1	$278K	Hold	5,000	–	–	0.02%	214
2021 Q4	$280K	Hold	5,000	–	–	0.02%	222
2021 Q3	$240K	Hold	5,000	–	–	0.02%	224
2021 Q2	$209K	Buy	+5,000	New	+$194K	0.02%	231

Other funds holding NVO

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Hodges Capital Management's NVO Position: Q2 2026 in Review

Hodges Capital Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 51,300 shares worth $2.46M. The stake represents 0.16% of the portfolio and ranks #125 among its holdings. This is a return to the name: Hodges Capital Management previously reported a position in NVO as recently as Q2 2025.

Hodges Capital Management first reported a position in NVO in Q2 2021 and has held it in 18 quarters since. The position peaked at $20.6M in Q4 2023. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Hodges Capital Management held 51,300 shares of Novo Nordisk worth $2.46M as of Q2 2026.
Novo Nordisk was a new Hodges Capital Management position in Q2 2026.
Novo Nordisk made up 0.16% of Hodges Capital Management's portfolio in Q2 2026, its #125 holding.
Hodges Capital Management first reported a position in Novo Nordisk in Q2 2021 and has held it in 18 quarters since.
Hodges Capital Management's Novo Nordisk position peaked at $20.6M in Q4 2023.
819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hodges Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.